Value‐based care in hepatology
Mario Strazzabosco, John I. Allen, Elizabeth O. Teisberg – 10 January 2017 – The migration from legacy fee‐for‐service reimbursement to payments linked to high‐value health care is accelerating in the United States because of new legislation and redesign of payments from the Centers for Medicare and Medicaid Services. Because patients with chronic diseases account for substantial use of health care resources, payers and health systems are focusing on maximizing the value of care for these patients.